Sun Pharma Aims for Top 3 in Women’s Health with $11.75B Organon Purchase
Sun Pharma and Organon said the combined company would rank among the top three in global women’s health, become the world’s seventh‑largest biosimilar player, and operate in 150 countries, including 18 large markets each generating more than $100 million in revenues. The post Sun Pharma Aims for Top 3 in Women’s Health with $11.75B Organon Purchase appeared first on GEN - Genetic Engineering and Biotechnology News.
Original Source
Read the full article at Genengnews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.